IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BCTX

Balance Sheet

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q4 2021
Cash & Equivalents9.856.8829.902.7110.4912.465.015.790.860.946.2413.6521.2528.1733.5037.4541.0444.5347.9857.27
Short-term Investments10.6915.92--7.467.37------------------------------
Accounts Receivable------------------0.020.030.020.020.010.010.030.02------
Total Current Assets22.0425.3932.1811.3519.9314.797.168.223.655.5311.7418.4126.9529.5033.9438.2242.3546.2348.3257.80
Property, Plant & Equipment0.320.350.250.270.300.320.340.370.39------0.00------0.00------
Intangible Assets0.17----0.180.180.190.190.200.200.200.210.210.220.220.220.230.23------
Total Non-current Assets1.531.681.421.731.722.222.202.202.220.670.490.210.220.220.220.230.23------
Total Assets23.5827.0733.5913.0821.6517.009.3610.415.876.2012.2318.6227.1629.7234.1638.4542.58------
Total Current Liabilities7.983.593.193.323.984.335.234.997.466.763.921.051.801.380.670.970.940.370.610.56
Total Non-current Liabilities0.040.070.200.410.340.730.911.711.105.6816.6215.0629.1434.2334.7727.1431.310.280.250.23
Total Liabilities*------------------------30.9435.6135.4428.1232.25------
Retained Earnings(146.66)(134.34)(127.17)(119.95)(111.76)(103.66)(97.54)(91.25)(85.44)(84.23)(85.95)(74.65)(80.65)(78.23)(73.34)(61.46)(60.35)(27.58)(22.76)(15.75)
Total Stockholder Equity------------------------(3.78)(5.89)(1.28)10.3310.3345.8247.7057.26
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
Research & Development10.535.976.056.687.114.815.683.674.417.668.266.865.173.863.053.263.17----
Selling, General & Admin2.051.651.481.641.441.521.481.491.361.571.571.652.541.821.432.152.07----
Total Operating Expenses12.587.627.538.328.556.337.175.155.779.239.838.50--5.684.495.40--4.853.93
Operating Income(12.58)(7.62)(7.53)(8.32)(8.55)(6.33)(7.17)(5.15)(5.77)(9.23)(9.83)(8.50)(7.71)(5.68)(4.49)(5.40)(5.23)(4.85)(3.93)
Interest Expense--------------------------0.000.000.00------
Net Income(12.32)(7.16)(7.22)(8.20)(8.09)(6.13)(6.29)(5.80)(1.21)1.72(11.29)6.00(2.42)(4.90)(11.88)(1.11)(0.45)----
Basic EPS--(0.99)(2.58)(4.35)(58.00)(1.64)(2.33)(0.22)(0.07)0.11(0.71)0.38(0.14)--(0.77)(0.07)--(0.32)--
Diluted EPS--(0.99)(2.58)(4.35)(58.00)(1.64)(2.33)(0.22)0.810.11(0.71)(0.50)(0.15)(0.32)(0.77)--------
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ4 2026Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q3 2022Q2 2022
Operating Cash Flow(5.96)(7.02)(7.97)(7.70)(8.13)(7.16)(5.92)(6.96)(4.04)(5.08)(7.40)(7.61)(10.92)(5.33)(3.95)(3.54)(9.16)(4.33)
Capital Expenditures--0.13--------------------------------
Free Cash Flow*--(7.15)--------------------------------
Investing Cash Flow4.99(16.00)7.28(0.07)(7.39)(0.10)(0.07)(0.07)(0.46)(0.22)----------------
Financing Cash Flow3.940.0027.87--13.5614.715.2211.96--------4.000.000.00(0.05)(3.58)(4.95)
← Scroll for more columns →

* Derived from reported values